Stockscreener 앱 받기
26.82
0.67%
-0.18
시간 외 거래:
26.82
전일 마감가:
$27.00
열려 있는:
$26.98
하루 거래량:
289.49K
Relative Volume:
0.96
시가총액:
$1.56B
수익:
-
순이익/손실:
-
주가수익비율:
-
EPS:
-
순현금흐름:
-
1주 성능:
+9.38%
1개월 성능:
+6.85%
6개월 성능:
+77.97%
1년 성능:
+0.00%
1일 변동 폭
$26.41
$27.63
1주일 범위
$24.32
$27.63
52주 변동 폭
$13.25
$30.00
Kestra Medical Technologies Ltd Stock (KMTS) Company Profile
명칭
Kestra Medical Technologies Ltd
전화
(425) 279-8002
주소
3933 LAKE WASHINGTON BLVD NE, KIRKLAND
KMTS을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
KMTS
Kestra Medical Technologies Ltd
|
26.82 | 1.58B | 0 | 0 | 0 | 0.00 |
|
ISRG
Intuitive Surgical Inc
|
556.86 | 196.60B | 9.61B | 2.77B | 2.27B | 7.555 |
|
BDX
Becton Dickinson Co
|
195.36 | 56.05B | 21.84B | 1.68B | 2.67B | 5.8293 |
|
ALC
Alcon Inc
|
79.26 | 38.81B | 10.19B | 1.05B | 1.38B | 2.1044 |
|
RMD
Resmed Inc
|
245.94 | 36.10B | 5.26B | 1.44B | 1.76B | 9.7713 |
|
WST
West Pharmaceutical Services Inc
|
269.13 | 19.17B | 2.96B | 487.70M | 344.00M | 6.6758 |
Kestra Medical Technologies Ltd Stock (KMTS) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-11-18 | 개시 | BTIG Research | Buy |
| 2025-03-31 | 개시 | BofA Securities | Buy |
| 2025-03-31 | 개시 | Goldman | Neutral |
| 2025-03-31 | 개시 | Piper Sandler | Overweight |
| 2025-03-31 | 개시 | Stifel | Buy |
| 2025-03-31 | 개시 | Wells Fargo | Overweight |
| 2025-03-31 | 개시 | Wolfe Research | Outperform |
모두보기
Kestra Medical Technologies Ltd 주식(KMTS)의 최신 뉴스
Is Kestra Medical Technologies (KMTS) Overvalued After Its Recent Share Price Climb? - simplywall.st
Kestra Medical prices upsized $138M offering - MSN
Kestra Medical Technologies (NASDAQ:KMTS) Shares Gap UpHere's What Happened - MarketBeat
Kestra Medical Technologies (KMTS) Q2: Revenue Growth, Losses Deepen, Testing Bullish Scale Narratives - simplywall.st
Wells Fargo Maintains Kestra Medical Technologies (KMTS) Overweight Recommendation - Nasdaq
Kestra Medical Technologies’ revenue up 53% to USD 22.6M in Q2 FY26 - Medical Buyer
Kestra Medical Technologies, Ltd. $KMTS Position Increased by Eventide Asset Management LLC - MarketBeat
Kestra Medical Technologies Reports Strong Earnings Growth - TipRanks
Wells Fargo Raises Price Target for KMTS, Maintains Overweight R - GuruFocus
Kestra Medical Technologies stock price target raised by Stifel to $30 - Investing.com Australia
Kestra Medical Technologies stock price target raised to $30 from $27 at Piper Sandler By Investing.com - Investing.com South Africa
Kestra Medical Technologies stock price target raised to $30 from $27 at Piper Sandler - Investing.com India
Kestra Medical price target raised to $30 from $27 at Piper Sandler - TipRanks
Kestra Medical Technologies: Strong Financial Performance and Market Leadership Drive Buy Rating - TipRanks
Kestra raises FY26 revenue guidance to $91M while targeting 70%+ gross margins with ASSURE system expansion - MSN
Is Kestra Medical Technologies Ltd a good long term investmentSector Performance Drivers & High Return Trading Strategies - earlytimes.in
Kestra Medical Technologies Ltd (KMTS) Q2 2026 Earnings Call Highlights: Revenue Surge and ... By GuruFocus - Investing.com Canada
Earnings call transcript: Kestra Medical Technologies Q2 2025 shows strong revenue growth By Investing.com - Investing.com South Africa
Earnings call transcript: Kestra Medical Technologies Q2 2025 shows strong revenue growth - Investing.com Australia
Kestra Medical raises FY26 revenue view to $91M from $88M, consensus $88.02M - TipRanks
Kestra Medical (KMTS) Q2 2026 Earnings Transcript - The Globe and Mail
Kestra Medical Technologies plunges 11% as quarterly loss exceeds estimates - Investing.com
Kestra Medical Technologies Q2 2026 Earnings Call Transcript - MarketBeat
KESTRA MEDICAL TECHNOLOGIES, LTD. SEC 10-Q Report - TradingView — Track All Markets
Kestra Medical reports Q2 EPS (64c), consensus (57c) - TipRanks
Kestra Medical Fiscal Q2 Loss Narrows, Revenue Rises; Fiscal 2026 Revenue Outlook Lifted - marketscreener.com
Kestra Medical Technologies plunges 11% as quarterly loss exceeds estimates By Investing.com - Investing.com South Africa
Kestra Medical Technologies Reports Second Quarter Fiscal 2026 Financial Results - TradingView — Track All Markets
Earnings Flash (KMTS) Kestra Medical Technologies, Ltd. Reports Q2 Revenue $22.6M, vs. FactSet Est of $20.7M - marketscreener.com
Kestra Medical Technologies announces public offering of common shares - MSN
A&O Shearman advised on Kestra Medical Technologies upsized USD158.7 million follow-on equity offering - A&O Shearman
Earnings To Watch: Kestra Medical Technologies Ltd (KMTS) Reports Q2 2025 Result - GuruFocus
Archimedes Vascular Announces Close of Series A Financing led by Sherpa Healthcare Partners and Appoints Raymond W. Cohen as Chairman of its Board of Directors - Quantisnow
Kestra Medical Technologies, Ltd. $KMTS Shares Sold by Omega Fund Management LLC - MarketBeat
Brown Advisory Inc. Increases Position in Kestra Medical Technologies, Ltd. $KMTS - Defense World
Assessing Kestra Medical Technologies (KMTS) Valuation After Its Recent Share Price Pullback - Yahoo Finance
Kestra Medical Technologies, Ltd. (NASDAQ:KMTS) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat
Kestra Medical Technologies, Ltd. (NASDAQ:KMTS) Given Average Rating of “Moderate Buy” by Brokerages - Defense World
Kestra Medical Raises $148.4 Million in Public Offering - TipRanks
Kestra Medical Technologies (NASDAQ:KMTS) Sees Unusually-High Trading VolumeTime to Buy? - MarketBeat
Can Kestra Medical Technologies Ltd. stock withstand economic slowdown2025 Sector Review & Safe Entry Point Alerts - Newser
Kestra Medical Technologies (KMTS): Assessing a 20x Sales Valuation After a Recent Double-Digit Daily Gain - simplywall.st
Will Kestra Medical Technologies Ltd. stock see PE expansionEarnings Miss & Consistent Profit Trading Strategies - Newser
Form 424B4 KESTRA MEDICAL TECHNOLOG - StreetInsider
Kestra Medical Technologies (Nasdaq: KMTS) sets Dec. 11 call to discuss Q2 fiscal 2026 results - Stock Titan
Kestra Medical Technologies, Ltd. to Report Second Quarter Fiscal 2026 Financial Results - marketscreener.com
Kestra Medical Technologies Prices Upsized Offering of 6 Million Shares - marketscreener.com
Kestra Medical Technologies Ltd (KMTS) 재무 분석
Kestra Medical Technologies Ltd (KMTS)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.
매출
순이익
현금흐름
주당 순 이익
1.26%
1.42%
자본화:
|
볼륨(24시간):